Author
UNSW SydneyORCID 0000-0002-0632-4589Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Alvin Kamili, Brandon A. Hearn, Isabella Temelkoska…·Jamie I. Fletcher
This study identifies venetoclax-alisertib as a promising combination therapy for high-risk neuroblastoma, particularly effective in MYCN-amplified models, with improved survival and reduced toxicity.
Jeremy Z. R. Han, Monica Phimmachanh, Jordan F. Hastings…·David R. Croucher
The paper identifies JNK-independent drugs that, when combined with standard chemotherapy, improve response in relapsed high-risk neuroblastoma by exploiting differential apoptotic network utilization.
Mujahid Azfar, Weiman Gao, Chris Van den Haute…·Klaartje Somers
This study identifies ATP13A3 as a polyamine transporter mediating DFMO-induced polyamine uptake in neuroblastoma, highlighting it as a therapeutic target.